Modeling the chemoprotective functions of glutathione S-transferases in cultured cell lines by heterologous expression

Drug Metabolism Reviews

Volumn 31, Issue 1, 1999, Pages 43-69

  Townsend, Alan J ^a,d   Fields, Wanda R ^b   Doss, Amanda J ^a   Clapper, Margie L ^c   Doehmer, Johannes ^a   Morrow, Charles S ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d RJR Research and Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; AFLATOXIN B1; BENZO[A]PYRENE; GLUTATHIONE TRANSFERASE; ISOENZYME; OLTIPRAZ;

ALKYLATION; ANIMAL CELL; CELL CULTURE; CHEMOPROPHYLAXIS; CONFERENCE PAPER; CYTOTOXICITY; DETOXIFICATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; MACROMOLECULE; NONHUMAN; TRANSGENE; TUMOR CELL LINE;

EID: 0032970751     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100101907     Document Type: Conference Paper

References (106)

1. LB. Weinstein, The origins of human cancer: Molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment-Twenty-seventh G.H.A. Clowes memorial lecture, Cancer Res., 48, 4135-4143 (1988).
2. T. D. Tlsty, A. Briot, A. Gualberto, I. Hall, S. Hess, M. Hixon, D. Kuppu-swamy, S. Romanov, M. Sage, and A. White, Genomic instability and cancer (Review), Mutât. Res., 337, 1-7 (1995).
3. L. A. Loeb, Mutator phenotype may be required for multistage carcinogenesis (Review), Cancer Res., 51, 3075-3079 (1991).
4. G. Powis and D. S. Alberts, Inhibiting intracellular signalling as a strategy for cancer chemoprevention, Eur. J. Cancer, 30a(8), 1138-1144 (1994).
5. I. Berenblum, Cancer prevention as a realizable goal, Cancer, 47, 2346-2348 (1981).
6. B. N. Ames, R. Magaw, and L. S. Gold, Ranking possible carcinogenic hazards, Science, 236, 271-280 (1987).
7. B. N. Ames, M. Profet, and L. S. Gold, Nature's chemicals and synthetic chemicals: Comparative toxicology, Proc. Natl. Acad. Sei. USA, 87, 7782-7786 (1990).
8. J. Higginson, Changing concepts in cancer prevention: Limitations and implications for future research in environmental carcinogenesis (Review), Cancer Res., 48, 1381-1389 (1988).
9. T. J. Slaga, Inhibition of the induction of cancer by antioxidants, Adv. Exp. Med. Biol, 369, 167-174 (1995).
10. P. J. O'Brien, Antioxidants and cancer: Molecular mechanisms, Adv. Exp. Med. Biol., 366, 215-239 (1994).
11. P. Cerutti, R. Ghosh, Y. Oya, and P. Amstad, The role of the cellular antioxidant defense in oxidant carcinogenesis (Review), Environ. Heatlh Perspect., 10, 123-129 (1994).
12. D. I. Feig, T. M. Reid, and L. A. Loeb, Reactive oxygen species in tumorigenesis (Review), Cancer Res., 54, 1890s-1894s (1994).
13. W. B. Jakoby, The Enzymatic Basis of Detoxification. Academic Press, New York, 1980.
14. P. J. Vickers, A. J. Townsend, and K. H. Cowan, Mechanisms of Resistance to Antineoplastic Dnigs, CRC Press, Boca Raton, FL, 1988, Vol. 2, pp. 117-152.
15. C. R. Wolf, Metabolic factors in cancer susceptibility (Review), Cancer Surveys, 9, 437-474 (1990).
16. A. Meister and M. Anderson, Glutathione, Ann. Rev. Biochem., 52, 711760 (1983).
17. A. Meister, Glutathione, ascorbate, and cellular protection, Cancer Res., 54, 1969s-1975s (1994).
18. S. Langouet, B. Coles, F. Morel, L. Becquemont, P. Beaune, F. P. Guengerich, B. Ketterer, and A. Guillouzo, Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B l metabolism in human hepatocytes in primary culture, Cancer Res., 55, 5574-5579 (1995).
19. K. J. Helzlsouer and T. W. Kensler, Cancer chemoprotection by oltipraz: Experimental and clinical considerations (Review), Prevent. Med., 22, 783-795 (1993).
20. B. Ketterer, Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis (Review), Mutât. Res., 202, 343-361 (1988).
21. M. Paolini, R. Mesirca, N. Gialluca, C. Bauer, G. L. Biagi, and F. G. Cantelli, On cancer chemoprevention: Complications and limitations of some proposed strategies, Carcinogenesis, 16, 971-972 (1995).
22. L. W. Wattenberg, What are the critical attributes for cancer chemopreventive agents? (Review), Ann. NY Acad. Sei., 768, 73-81 (1995).
23. G. J. Kelloff, C. W. Boone, V. E. Steele, J. R. Fay, R. A. Lubet, J. A. Crowell, and C. C. Sigman, Mechanistic considerations in chemopreventive drug development, J. Cell Biochem., 20, 1-24 (1994).
24. C. W. Boone and L. W. Wattenberg, Current strategies of cancer chemoprevention: 13th Sapporo Cancer Seminar, Cancer Res., 54, 3315-3318 (1994).
25. T. Kensler, P. Styczynski, J. Groopman, K. Helzlsouer, T. Curphey, Y. Maxuitenko, and B. D. Roebuck, Mechanisms of chemoprotection by oltipraz, J. Cell Biochem., Suppl.: 167-172 (1992).
26. P. A. Egner, T. W. Kensler, T. Prestera, P. Talalay, A. H. Libby, H. H. Joyner, and T. J. Curphey, Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones, Carcinogenesis, 15, 177-181 (1994).
27. M. L. Clapper, L. C. Everley, L. A. Strobel, A. J. Townsend, and P. F. Engstrom, Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz, Molec. Pharmacol., 45, 469-474 (1994).
28. L. Anderson, V. K. Steele, G. J. Kelloff, and S. Sharma, Effects of oltipraz and related chemoprevention compounds on gene expression in rat liver (Review), J. Cell. Biochem., 22(Suppl.), 108-116 (1995).
29. S. J. Stohs, T. A. Lawson, L. Anderson, and E. Bueding, Effects of oltipraz, BHA, ADT and cabbage on glutathione metabolism, DNA damage and lipid peroxidation in old mice, Mech. Ageing Devel., 37, 137-145 (1986).
30. T. Primiano, P. A. Egner, T. R. Sutler, G. J. Kelloff, B. D. Roebuck, and T. W. Kensler, Intermittent dosing with oltipraz: Relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases, Cancer Res., 55, 4319-4324 (1995).
31. G. M. Williams and M. J. latropoulos, Inhibition of the hepatocarcinogenicity of aflatoxin Bl in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene, Cancer Lett., 104,49-53 (1996).
32. T. W. Kensler, P. A. Egner, N. E. Davidson, B. D. Roebuck, A. Pikul,a and J. D. Groopman, Modulation of aflatoxin metabolism, aflatoxin-N7guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases, Cancer Res., 46, 3924-3931 (1986).
33. V. L. Sparnins, G. Barany, and L. W. Wattenberg, Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse, Carcinogenesis, 9, 131-134 (1988).
34. T. J. Monks, M. W. Anders, W. Dekant, J. L. Stevens, S. S. Lau, and P. J. van Bladeren, Glutathione conjugate mediated toxicities, Toxicol. Appl. Phannacol., 106, 1-19 (1990).
35. F. P. Guengerich, Metabolism and genotoxicity of dihaloalkanes (Review), Adv. Phannacol., 27, 211-236 (1994).
36. T. P. Simula, M. J. Glancey, and C. R. Wolf, Human glutathione S-transferase-expressing Salmonella typhimurium tester strains to study the activation/detoxification of mutagenic compounds: Studies with halogenated compounds, aromatic amines and aflatoxin Bl, Carcinogenesis, 14, 1371-1376 (1993).
37. D. Nebert, D. Petersen, and J. A. Fornace, Cellular responses to oxidative stress: The [AH] gene battery as a paradigm., Environ. Health Perspect., 88, 13-25 (1990).
38. V. Daniel, Glutathione S-transferases: Gene structure and regulation of expression, Crit. Rev. Biochem. Molec. Biol., 28, 173-207 (1993).
39. T. M. Buetler, E. P. Gallagher, C. Wang, D. L. Stahl, J. D. Hayes, and D. L. Eaton, Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz, Toxicol. Appl. Phannacol., 135, 45-57 (1995).
40. R. Pinkus, L. M. Weiner, and V. Daniel, Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression, J. Biol. Chem., 271, 13422-13429 (1996).
41. D. J. Pulford and J. D. Hayes, Characterization of the rat glutathione S-transferase Yc2 subunit gene, GSTA5: Identification of a putative antioxidant-responsive element in the 5′-flanking region of rat GSTA5 that may mediate chemoprotection against aflatoxin Bl, Biochem. J., 318, 75-84 (1996).
42. S. X. Liu and C. B. Pickett, The rat liver glutathione S-transferase Ya subunit gene: Characterization of the binding properties of a nuclear protein from HepG2 cells that has high affinity for the antioxidant response element, Biochemistry, 35, 11517-11521 (1996).
43. B. Mannervik, Evolution of glutathione transferases and related enzymes for the protection of cells against electrophiles, Biochem. Soc. Trans., 24, 878-880 (1996).
44. B. Mannervik and U. H. Danielson, Glutathione transferases-structure and catalytic activity (Review), Crif. Rev. Biochem., 23, 283-337 (1988).
45. J. D. Hayes and D. J. Pulford, The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance, CriJ. Rev. Biochem. Molec. Biol., 30, 445-600 (1995).
46. B. Ketterer, D. J. Meyer, J. B. Taylor, S. Pemble, B. Coles, and G. Fraser, GSTs and protection against oxidative stress, in Glutatione S-Transferases and Drug Resistance (J. D. Hayes, C. B. Pickett, and T. J. Mantle, eds.), Taylor and Francis, London, 1990, pp. 97-110.
47. J. N. Commandeur, G. J. Stijntjes, and N. P. Vermeulen, Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms ofxenobiotics (Review), Pharmacol. Rev., 47, 271-330 (1995).
48. C. Pickett, Glutathione S-transferases: Gene structure, regulation, and biological function, Anna. Rev. Biochem., 58, 743-764 (1989).
49. D. E. Moody, B. A. Narloch, L. R. Shull, and B. D. Hammock, The effect of structurally divergent herbicides on mouse liver xenobiotic-metabolizing enzymes (P-450-dependent mono-oxygenases, epoxide hydrolases and glutathione S-transferases) and carnitine acetyltransferase, Toxicol. Lett., 59, 175-185 (1991).
50. A. J. Townsend and K. H. Cowan, Glutathione S-transferases and drug resistance (Review), Cancer Bull., 41, 31-37 (1989).
51. C. S. Morrow and K. H. Cowan, Glutathione S-transferases and drug resistance, Cancer Cells, 2, 15-17 (1990).
52. S. M. Black and C. R. Wolf, The role of glutathione-dependent enzymes in drug resistance (Review), Pharmacol. Therapeut., 51, 139-154 (1991).
53. R. B. Puchalski and W. E. Fahl, Expression of recombinant glutathione S-transferase pi, Ya, or Ybl confers resistance to alkylating agents, Proc. Natl. Acad. Sei. USA, 87, 2443-2447 (1990).
54. T. H. Manoharan, P. J. Welch, A. M. Gulick, R. B. Puchalski, A. L. Lathrop, and W. E. Fahl, Expression of tandem glutathione S-transferase recombinant genes in COS cells for analysis of efficiency of protein expression and associated drug resistance, Molec. Pharmacol., 39,461-467 (1991).
55. M. Miyazaki, K. Kohno, Y. Saburi, K. Matsuo, M. Ono, M. Kuwano, S. Tsuchida, K. Sato, M. Sakai, and M. Muramatsu, Drug resistance to cisdiamminedichloroplatinum(II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase Pi gene, Biochem. Biophys. Res. Commun., 166, 1358-1364 (1990).
56. K. Nakagawa, N. Saijo, S. Tsuchida, M. Sakai, Y. Tsunokawa, J. Yokota, M. Muramatsu, K. Sato, M. Terada, and K. D. Tew, Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines, J. Biol. Chem., 265, 4296-4301 (1990).
57. A. J. Townsend, M. E. Goldsmith, C. B. Pickett, and K. H. Cowan, Isolation, characterization, and expression in Escherichia coli of two murine mu class glutathione S-transferase cDNAs homologous to the rat subunits 3 (Ybl) and 4 (Yb2), J. Biol. Chem., 264, 21582-21590 (1989).
58. B. Leyland-Jones, A. J. Townsend, C. P. Tu, K. H. Cowan, and M. E. Goldsmith, Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase gene, Cancer Res., 51, 587-594 (1991).
59. J. A. Moscow, A. J. Townsend, and K. H. Cowan, Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GSTit gene and its effect on sensitivity to toxins, Molec. Pharmacol., 36, 22-28 (1989).
60. I. Leier, G. Jedlitschky, U. Buchholz, S. Cole, R. G. Deeley, and D. Keppler, The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates, J. Biol. Chem., 269, 27807-27810 (1994).
61. M. Müller, C. Meijer, G. Zaman, P. Borst, R. J. Scheper, N. H. Mulder, E. De Vries, and P. Jansen, Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport, Proc. Natl. Acad. Sei. USA, 91, 1303313037 (1994).
62. D. Keppler, I. Leier, and G. Jedlitschky, Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2 (Review), Biol. Chem., 378, 787-791 (1997).
63. S. Paul, L. M. Breuninger, K. D. Tew, H. X. Shen, and G. D. Kruh, ATPdependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter, Proc. Natl. Acad. Sei. USA, 93, 6929-6934 (1996).
64. C. E. Grant, G. Valdimarsson, D. R. Hipfner, K. C. Almquist, S. Cole, and R. G. Deeley, Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs, Cancer Res., 54, 357-361 (1994).
65. H. X. Shen, S. Paul, L. M. Breuninger, P. J. Ciaccio, N. M. Laing, M. Kelt, K. D. Tew, and G. D. Kruh, Cellular and in vitro transport of glutathione conjugates by MRP, Biochemistry, 35, 5719-5725 (1996).
66. M. Müller, V. E. De, and P. Jansen, Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells, J. Hepatol., 1, 100-108 (1996).
67. L. Pulaski, G. Jedlitschky, I. Leier, U. Buchholz, and D. Keppler, Identifi-cation of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes, Eitr. J. Biochem., 241, 644-648 (1996).
68. C. S. Morrow, S. Diah, P. K. Smitherman, E. Schneider, and A. J. Townsend, Multidrug resistance protein and glutathione S-transferase Pl-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity, Carcinogenesis, 19, 109-115 (1998).
69. W. R. Fields, Y. Li, and A. J. Townsend, Protection by transfected glutathione S-transferase isozymes against carcinogen-induced alkylation of cellular macromolecules in human MCF-7 cells, Carcinogenesis, 15, 1155-1160(1994).
70. C. S. Morrow, P. K. Smitherman, S. K. Diah, E. Schneider, and A. J. Townsend, Coordinated action of glutathione S-transferases (GST) and multidrug resistance protein (MRP) in antineoplastic drug detoxification: Mechanism of GSTA1-1- and MRP-associated resistance to chlorambucil in MCF-7 breast carcinoma cells, J. Biol. Chein., 273, 20114-20120 (1998).
71. A. P. Simula, M. B. Crichton, S. M. Black, S. Pemble, H. F. Bligh, J. D. Beggs, and C. R. Wolf, Heterologous expression of drug-metabolizing enzymes in cellular and whole animal models (Review), Toxicology, 82, 3-20 (1993).
72. R. Langenbach, P. B. Smith, and C. Crespi, Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology (Review), Mutât. Res., 277, 251-275 (1992).
73. A. J. Townsend, C. P. Tu, and K. H. Cowan, Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: Effect on cellular sensitivity to cytotoxic agents, Molec. Phannacol., 41, 230-236 (1992).
74. C. S. Morrow, J. Chiu, and K. H. Cowan, Posttranscriptional control of glutathione S-transferase pi gene expression in human breast cancer cells, J. Biol. Chetn., 267, 10544-10550 (1992).
75. K. D. Bunting and A. J. Townsend, De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines, J. Biol. Chem., 271, 11884-11890 (1996).
76. J. A. Moscow, C. R. Fairchild, M. J. Madden, D. T. Ransom, H. S. Wieand, E. E. O'Brien, D. G. Poplack, J. Cossman, C. E. Myers, and K. H. Cowan, Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors, Cancer Res., 49, 1422-1428 (1989).
77. D. M. Rhoads, R. P. Zarlengo, and C. P. Tu, The basic glutathione Stransferases from human livers are products of separate genes, Biochem. Biophys. Res. Commun., 145, 474-481 (1987).
78. J. L. DeJong, C.-M. Chang, J. Whang-Peng, T. Knutsen, and C.-P. D. Tu, The human liver glutathione S-transferase gene superfamily: Expression and chromosome mapping of an Hb subunit cDNA, Nucl. Acids Res., 16, 8541-8554 (1988).
79. T. M. Buetler and D. L. Eaton, Complementary DNA cloning, messenger RNA expression, and induction of alpha-class glutathione S-transferases in mouse tissues, Cancer Res., 52, 314-318 (1992).
80. A. J. Townsend, M. E. Goldsmith, C. B. Pickett, and K. H. Cowan, Isolation, characterization, and expression in Escherichia coli of two murine mu class glutathione S-transferase cDNAs homologous to the rat subunits 3 (Ybl) and 4 (Yb2), J. Biol. Chem., 264, 21582-21590 (1989).
81. S. Dogra, J. Doehmer, H. Glatt, H. Molders, P. Siegert, T. Freidberg, A. Seidel, and F. Oesch, Stable expression of rat cytochrome P-4501A1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing, Mol. Phann., 37, 608-613 (1990).
82. J. Doehmer, S. Dogra, T. Friedberg, S. Monier, M. Adesnik, H. Glatt, and F. Oesch, Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin B l, Proc. Natl. Acad. Sei. USA, 85, 5769-5773 (1988).
83. E. Schneider, J. K. Horton, C. H. Yang, M. Nakagawa, and K. H. Cowan, Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance, Cancer Res., 54, 152-158 (1994).
84. W. R. Fields, C. S. Morrow, and A. J. Townsend, Overexpression of stably transfected human glutathione S-transferase (GST) Pl-1 protects against DNA damage by benzo[a]pyrene diol epoxide (BPDE) in human T47D cells, Molec. Pharmacol., 54, 298-304 (1998).
85. A. J. Townsend, W. R. Fields, R. L. Haynes, A. J. Karper, Y. Li, J. Doehmer, and C. S. Morrow, Chemoprotective functions of glutathione S-transferases in cell lines induced to express specific isozymes by stable transfection, Chem. Biol. Interact., 111-112, 389-407 (1998).
86. P. Sims, The metabolic activation of chemical carcinogens (Review), Er. Med. Bull., 36, 11-18(1980).
87. T. Shimada, M. V. Martin, S. D. Pruess, L. J. Marnett, and F. P. Guengerich, Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons, Cancer Res., 49, 6304-6312 (1989).
88. S. J. Wei, R. L. Chang, E. Hennig, X. X. Cui, K. A. Merkler, C. Q. Wong, H. Yagi, D. M. Jerina, and A. H. Conney, Mutagenic selectivity at the HPRT locus in V-79 cells: Comparison of mutations caused by bay-region benzo[a]pyrene 7,8-diol-9,10-epoxide enantiomers with high and low carcinogenic activity, Carcinogenesis, 15, 1729-1736 (1994).
89. S. J. Wei, R. L. Chang, N. Bhachech, X. X. Cui, K. A. Merkler, C. Q. Wong, E. Hennig, H. Yagi, D. M. Jerina, and A. H. Conney, Dose-dependent differences in the profile of mutations induced by (+)-7R,8S-dihydroxy-95,10R-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V-79 cells, Cancer Res., 53, 3294-3301 (1993).
90. I. G. Robertson, C. Guthenberg, B. Mannervik, and B. Jemstrom, Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7 beta,8 alphadihydroxy-9 alpha,10 alpha-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene, Cancer Res., 46, 2220-2224 (1986).
91. P. Vickers, M. Dufresne, and K. Cowen, Relation between cytochrome P4501A1 expression and estrogen receptor content of human breast cancer cells, Mol. EndocrinoL, 3, 157-164 (1989).
92. H. Glatt, I. Gemperlein, G. Turchi, H. Heinritz, J. Doehmer, and F. Oesch, Search for cell culture systems with diverse xenobiotic-metabolizing activities and their use in toxicological studies (Review), Molec. Toxicol., 1, 313-334(1987).
93. M. McLean and M. F. Dutton, Cellular interactions and metabolism of aflatoxin: An update, Pharmacol. Ther., 65, 163-192 (1995).
94. D. L. Eaton and E. P. Gallagher, Mechanisms of aflatoxin carcinogenesis (Review), Annu. Rev. Pharmacol. Toxicol., 34, 135-172 (1994).
95. T. M. Buetler, D. Slone, and D. L. Eaton, Comparison of the aflatoxin Bl-8,9-epoxide conjugating activities of two bacterially expressed alpha class glutathione S-transferase isozymes from mouse and rat, Blochem. Biophys. Res. Commun., 188, 597-603 (1992).
96. J. D. Hayes, D. J. Judah, L. I. McLellan, L. A. Kerr, S. D. Peacock, and G. E. Neal, Ethoxyquin-induced resistance to aflatoxin Bl in the rat is associated with the expression of a novel Alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin Bl-8,9-epoxide, Biochem. J., 279, 385-398 (1991).
97. W. W. Johnson, T. M. Harris, and F. P. Guengerich, Kinetics and mechanism of hydrolysis of aflatoxin Bl exo-8,9-epoxide and rearrangement of the dihydrodiol, J. Am. Chem. Soc., 118, 8213-8220 (1996).
98. M. Merlos, R. M. Sanchez, J. Camarasa, and T. Adzet, Flavonoids as inhibitors of rat liver cytosolic glutathione S-transferase, Experientia, 47, 616-619 (1991).
99. H. Ahmad, S. V. Singh, and Y. C. Awasthi, Inhibition of bovine lens glutathione S-transferases by hematin, bilirubin, and bromosulfophthalein, Lens Eye Toxic Res., 8, 431-440 (1991).
100. K. Datta and A. P. Kulkarni, Inhibition of mammalian hepatic glutathione S-transferases by acetylenic fatty acids, Toxicol. Lett., 73, 157-165 (1994).
101. J. D. Hayes and J. Chalmers, Bile acid inhibition of basic and neutral glutathione S-transferases in rat liver, Biochem. J., 215, 581-588 (1983).
102. J. Bogaards, J. C. Venekamp, and B. P. Van, Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases Al-1, A2-2, Mla-la, and Pl-1, Chem. Res. Toxicol., 10, 310-317 (1997).
103. I. Listowsky, M. Abramovitz, H. Homma, and Y. Niitsu, Intracellular binding and transport of hormones and xenobiotics by glutathione-S-transferases (Review), Dnig Metab. Rev., 19, 305-318 (1988).
104. F. Redegeld, G. A. Hofman, P. G. F. Van de Loo, A. S. Koster, and J. Noordhoek, Nephrotoxicity of the glutathione conjugate of menadione (2-methyl-l,4-naphthoquinone) in the isolated perfused rat kidney. Role of metabolism by gamma-glutamyltranspeptidase and probenecid-sensitive transport. J. Pharmacol. Exp. Ther., 256, 665-669 (1991).
105. J. J. Horvath, C. M. Witmer, and G. Witz, Nephrotoxicity of the 1:1 acrolein-glutathione adduct in the rat, Toxicol. Appl. Pharmacol., 117, 200207 (1992).
106. K. Ramu, C. S. Perry, T. Ahmed, G. Pakenham, and J. P. Kehrer, Studies on the basis for the toxicity of acrolein mercapturates, Toxicol. Appl. Pharmacol., 140, 487-498 (1996).